Global Retirement Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.87K Buy
+291
New +$5.87K ﹤0.01% 3646
2025
Q4
$31.4K Buy
1,174
+150
+15% +$3.86K ﹤0.01% 2639
2025
Q3
$27.3K Buy
1,024
+703
+219% +$18.2K ﹤0.01% 2248
2025
Q2
$7.37K Buy
+321
New +$7.97K ﹤0.01% 2740
2024
Q4
$6.54K Buy
176
+6
+4% +$274 ﹤0.01% 2565
2024
Q3
$8.25K Sell
170
-22
-11% -$965 ﹤0.01% 2366
2024
Q2
$7.68K Buy
192
+145
+309% +$6.01K ﹤0.01% 2429
2024
Q1
$2.06K Sell
47
-49
-51% -$2.53K ﹤0.01% 2742
2023
Q4
$5.33K Buy
96
+68
+243% +$3.57K ﹤0.01% 2298
2023
Q3
$1.28K Buy
28
+2
+8% +$109 ﹤0.01% 2697
2023
Q2
$1.49K Buy
26
+15
+136% +$665 ﹤0.01% 2648
2023
Q1
$399 Hold
11
– – ﹤0.01% 2972
2022
Q4
$308 Hold
11
– – ﹤0.01% 2866
2022
Q3
$0 Buy
11
+3
+38% +$98 ﹤0.01% 2673
2022
Q2
$0 Buy
+8
New +$285 ﹤0.01% 2663

Other funds holding AMPH

Global Retirement Partners's AMPH Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2026: 291 shares worth $5.87K. The stake represents ﹤0.01% of the portfolio and ranks #3646 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in AMPH as recently as Q4 2025.

Global Retirement Partners first reported a position in AMPH in Q2 2022 and has held it in 15 quarters since. The position peaked at $31.4K in Q4 2025. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Global Retirement Partners held 291 shares of Amphastar Pharmaceuticals worth $5.87K as of Q2 2026.
  • Amphastar Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3646 holding.
  • Global Retirement Partners first reported a position in Amphastar Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
  • Global Retirement Partners's Amphastar Pharmaceuticals position peaked at $31.4K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.